معرفی
Dekker C. Deacon, MD, PhD, FAAD, serves as a Clinical Assistant Professor in the Department of Dermatology at the University of Utah, practicing at Huntsman Cancer Institute and University of Utah Hospital. He specializes in skin cancer treatment, particularly melanoma and cutaneous oncology, and provides comprehensive general dermatology care for conditions ranging from psoriasis to skin infections. As an active member of the Melanoma Disease Center, he participates in weekly multidisciplinary treatment planning conferences.
His educational journey includes:
- Bachelor of Arts in Molecular Biology and Biochemistry from Middlebury College
- MD and PhD in Biomedical Sciences from University of California, San Diego (Medical Scientist Training Program)
- Internal Medicine Preliminary Internship at University of Utah School of Medicine
- Dermatology Residency and Chief Residency at University of Utah School of Medicine
Dr. Deacon's research centers on skin cancer genetics, with emphasis on melanoma biomarkers and molecular mechanisms. His clinical work integrates cutting-edge genomic insights with patient care, focusing on early detection and personalized treatment strategies for skin malignancies. He treats diverse dermatological conditions while maintaining subspecialty expertise in complex oncology cases.
Analysis of his 15 most recent publications reveals consistent focus on melanoma molecular subtypes (particularly acral and amelanotic variants), microRNA-based diagnostics, and novel therapeutic approaches including transdermal drug delivery systems. His work bridges genomic discovery with clinical translation, emphasizing tumor microenvironment interactions and ancestry-related genetic factors.
Professional recognition includes:
- Fellow of the American Academy of Dermatology (FAAD)
Dr. Deacon actively contributes to academic dermatology through clinical teaching and research mentorship within the residency program. His collaborative work with multidisciplinary oncology teams ensures comprehensive cancer care delivery. Patient testimonials consistently highlight his diagnostic expertise, compassionate communication, and effective treatment planning across both cancer and general dermatology contexts.
He maintains active clinical-research integration through the Melanoma Disease Center at Huntsman Cancer Institute, working alongside surgical oncologists, medical oncologists, pathologists, and radiation specialists to develop individualized treatment protocols. His dual MD/PhD training enables unique contributions to translational research in skin cancer therapeutics.